StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
16
This year
1
Publishing Date
2024 - 01 - 22
1
2023 - 09 - 22
1
2023 - 08 - 28
1
2023 - 08 - 25
1
2023 - 07 - 05
1
2023 - 01 - 18
1
2022 - 11 - 03
1
2022 - 09 - 06
1
2022 - 08 - 03
1
2022 - 07 - 13
1
2022 - 04 - 06
1
2022 - 03 - 01
1
2021 - 12 - 10
1
2021 - 12 - 01
1
2021 - 06 - 24
1
2021 - 04 - 16
1
Sector
Health technology
16
Manufacturing
1
Process industries
1
Tags
Active
1
Artificial intelligence
1
Camzyos
1
Cancer
4
Cancer drug
1
Clinical-trials-phase-iii
1
Covid
1
Covid-19
1
Disease
1
Drug
3
Expected
1
Fibrosis
1
Food
1
Genetown
1
Global
5
Growing
1
Growth
3
Health
1
Il-12
1
Immunotherapy
2
Impact
1
Infection
1
Market
10
Milestone
1
Million
1
N/a
13
Nivolumab
1
One
1
Phase 1
1
Phase 2
1
Product-news
1
Program
1
Reach
2
Report
3
Research
2
Response
1
Study
1
Therapeutics
1
Therapy
3
Treatment
6
Entities
Abbott laboratories
2
Abbvie inc.
2
Albemarle corporation
1
Amgen inc.
5
Astrazeneca plc
3
Bristol-myers squibb company
16
Cumberland pharmaceuticals inc.
1
Eli lilly and company
6
Galapagos nv
1
Gilead sciences, inc.
2
Glaxosmithkline plc
3
Johnson & johnson
7
Liminal biosciences inc.
1
Merck & company, inc.
1
Mesoblast limited
1
Mirati therapeutics, inc.
1
Novartis ag
8
Oncolytics biotech inc.
1
Pfizer, inc.
1
Sanofi
6
Takeda pharmaceutical company limited
2
Teva pharmaceutical industries ltd
2
Ucb s.a.
1
Vericel corporation
1
Viatris inc.
1
Symbols
AAPL
52
ABB
57
ABBV
32
ABLZF
47
ABT
92
ACAQ
37
ACM
34
ARVL
226
AZN
33
BDX
55
BNPQF
210
BNPQY
210
CNXC
39
DHR
42
DNZOF
35
DNZOY
35
DUK
45
ERIC
61
EXPR
31
EXTR
35
FE
79
FLNT
40
FNCTF
380
FST
35
GE
45
GLAXF
33
GSK
40
HON
59
HRL
32
INTC
53
JNJ
165
LLY
53
LMNR
32
LYV
53
MDT
61
MMM
42
MS
114
MSFT
62
NBR
31
NIPNF
32
NOK
199
NOKBF
200
NVS
45
NVSEF
43
ORCL
46
PCRFF
44
PCRFY
44
PHG
42
PPRUF
38
PPRUY
38
SAP
58
SAPGF
50
SNOW
93
SNY
153
SNYNF
120
SO
35
TMO
77
TOL
63
VSAC
59
VZ
57
Exchanges
Nasdaq
13
Nyse
16
Crawled Date
2024 - 01 - 22
1
2023 - 09 - 22
1
2023 - 08 - 28
1
2023 - 08 - 25
1
2023 - 07 - 05
1
2023 - 01 - 18
1
2022 - 11 - 03
1
2022 - 09 - 06
1
2022 - 08 - 03
1
2022 - 07 - 13
1
2022 - 04 - 06
1
2022 - 03 - 01
1
2021 - 12 - 10
1
2021 - 12 - 01
1
2021 - 06 - 24
1
2021 - 04 - 16
1
Crawled Time
00:00
18
00:01
1
01:00
10
02:00
6
03:00
3
04:00
2
04:20
3
05:00
1
06:00
3
07:00
4
08:00
11
08:20
1
09:00
5
10:00
8
10:41
1
10:43
1
10:51
2
10:57
1
11:00
22
11:36
1
12:00
108
12:01
1
12:02
1
12:04
1
12:15
15
12:20
17
12:24
1
12:30
10
12:34
1
13:00
67
13:07
1
13:13
1
13:15
4
13:17
1
13:20
10
13:27
1
13:30
8
13:50
1
14:00
38
14:03
1
14:15
1
14:20
7
14:30
7
14:58
1
15:00
29
15:15
2
15:20
4
15:30
6
16:00
31
16:20
3
17:00
24
18:00
22
18:04
2
18:26
2
18:31
2
19:00
16
20:00
25
21:00
27
22:00
22
23:00
18
Source
www.biospace.com
3
www.prnewswire.com
13
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Bmy
crawled time :
19:00
save search
Global Urinary Tract Infection (UTI) Treatment Market is expected to Reach US$ 13,617.4 million by 2034, rising at a 1.9% CAGR- FMI Study
Published:
2024-01-22
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
0.5%
|
O:
-2.34%
H:
0.43%
C:
0.43%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-10.61%
|
O:
-1.11%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
0.18%
|
O:
-0.76%
H:
0.38%
C:
0.13%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-2.64%
|
O:
0.22%
H:
1.49%
C:
0.89%
expected
million
reach
infection
treatment
global
study
market
Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Projected to Reach $6.17 Billion by 2030: Increasing Prevalence Drives Growth
Published:
2023-09-22
(Crawled : 19:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
GLPGF
|
News
|
$35.5157
71.75%
4.8K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
LMNL
|
$8.5
0.12%
0.12%
0
|
Health Technology
|
Email alert
Add to watchlist
GLPG
|
News
|
$28.9
-1.1%
-1.11%
140K
|
Health Technology
|
Email alert
Add to watchlist
reach
treatment
fibrosis
global
growth
market
Long-Term Follow-Up Data from Two Phase 3 Studies of CAMZYOS® (mavacamten) Demonstrate Consistent and Durable Response in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)
Published:
2023-08-28
(Crawled : 19:00)
- biospace.com/
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-22.26%
|
O:
-0.03%
H:
0.56%
C:
-0.68%
camzyos
response
Global Hemorrhagic Shock Treatment Market Projected to Expand at a CAGR of 4.4%, Reaching $279.5 Million by 2030
Published:
2023-08-25
(Crawled : 19:00)
- prnewswire.com
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
treatment
global
market
Active Pharmaceutical Ingredients (API) Market Outlook 2028, the Market to Witness Investment of USD 312.37 Billion in the Next 6 Years - Arizton
Published:
2023-07-05
(Crawled : 19:00)
- prnewswire.com
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
61.21%
|
O:
-0.55%
H:
0.97%
C:
0.02%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-25.44%
|
O:
-1.65%
H:
0.39%
C:
-0.35%
ALB
|
News
|
$111.8
-2.26%
0.63%
2.2M
|
Process Industries
|
-49.52%
|
O:
-1.55%
H:
1.1%
C:
0.93%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-12.98%
|
O:
-1.74%
H:
0.0%
C:
0.0%
active
market
Dermatology Drugs Market to Experience Substantial Growth of USD 37.33 Million by 2029, Size, Share, Growth Rate, Market Demand, Opportunities and Competitive Landscape: Report by Data Bridge Market Research
Published:
2023-01-18
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-4.71%
|
O:
1.26%
H:
1.19%
C:
1.19%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
1.0%
|
O:
-0.1%
H:
0.31%
C:
0.17%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-14.72%
|
O:
-0.43%
H:
1.33%
C:
0.3%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-33.1%
|
O:
0.29%
H:
2.1%
C:
1.94%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-7.34%
|
O:
-0.92%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
0.96%
|
O:
-0.9%
H:
0.58%
C:
0.01%
research
report
growth
market
Pediatric Health Market Research Report by Type, Therapeutics, Treatment, Treatment Type, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-11-03
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
6.86%
|
O:
-0.02%
H:
0.43%
C:
0.43%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
11.87%
|
O:
-1.02%
H:
2.67%
C:
0.18%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
41.88%
|
O:
2.28%
H:
0.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
14.79%
|
O:
0.83%
H:
1.33%
C:
-0.51%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
15.8%
|
O:
1.13%
H:
0.63%
C:
0.53%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
107.58%
|
O:
0.97%
H:
0.18%
C:
-2.13%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-38.51%
|
O:
0.42%
H:
0.59%
C:
-0.04%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
11.9%
|
O:
1.43%
H:
0.41%
C:
0.25%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
8.67%
|
O:
2.05%
H:
0.0%
C:
0.0%
GILD
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-15.77%
|
O:
-0.4%
H:
2.75%
C:
1.52%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
13.91%
|
O:
0.72%
H:
1.29%
C:
1.04%
covid-19
treatment
research
global
report
impact
health
market
Disease-Modifying Antirheumatic Drug (DMARD) Market to Surpass US$ 27,167.8 Million by 2030 - Coherent Market Insights
Published:
2022-09-06
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
17.12%
|
O:
-3.02%
H:
0.0%
C:
0.0%
UCBJY
|
$64.07
-4.38%
72K
|
Manufacturing
|
86.52%
|
O:
0.73%
H:
2.28%
C:
1.72%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-11.71%
|
O:
-0.65%
H:
0.93%
C:
0.71%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-29.7%
|
O:
0.03%
H:
1.18%
C:
0.13%
ABBV
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
19.14%
|
O:
-0.03%
H:
1.08%
C:
0.84%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
15.75%
|
O:
0.49%
H:
0.0%
C:
0.0%
GILD
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
5.58%
|
O:
0.44%
H:
2.03%
C:
1.76%
CPIX
|
$1.57
6.02%
1.4K
|
Health Technology
|
-29.41%
|
O:
-4.52%
H:
7.12%
C:
5.69%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
10.2%
|
O:
0.24%
H:
1.04%
C:
0.82%
drug
market
Global Cancer Therapies Market Report 2022: Market to Reach $209.2 Billion by 2026 - Industry Focuses on New Approaches to Treat Cancer
Published:
2022-08-03
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-1.46%
|
O:
-1.22%
H:
1.8%
C:
1.8%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
3.84%
|
O:
2.52%
H:
0.0%
C:
-0.19%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
28.56%
|
O:
-2.88%
H:
0.0%
C:
-0.21%
TAK
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-5.33%
|
O:
-0.29%
H:
0.72%
C:
0.58%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-49.02%
|
O:
0.08%
H:
0.29%
C:
-0.08%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
9.69%
|
O:
0.2%
H:
0.44%
C:
0.24%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-16.1%
|
O:
1.4%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-2.99%
|
O:
0.27%
H:
0.1%
C:
-0.81%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
139.23%
|
O:
-1.16%
H:
0.02%
C:
-1.42%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-33.88%
|
O:
-0.27%
H:
0.22%
C:
-0.92%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
4.51%
|
O:
1.13%
H:
0.35%
C:
0.35%
global
report
cancer
market
Global Crohn's Disease Treatment Market to Surpass US$ 15.17 Billion by 2030 - Coherent Market Insights
Published:
2022-07-13
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-6.51%
|
O:
-1.46%
H:
0.09%
C:
0.09%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
35.22%
|
O:
-1.35%
H:
0.4%
C:
0.27%
TAK
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-7.59%
|
O:
-0.7%
H:
0.21%
C:
0.07%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
12.13%
|
O:
-1.04%
H:
0.62%
C:
0.55%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
132.83%
|
O:
-1.53%
H:
3.22%
C:
2.94%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-35.25%
|
O:
-1.19%
H:
0.66%
C:
0.5%
ABBV
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
7.74%
|
O:
-2.18%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-6.89%
|
O:
-1.27%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
8.03%
|
O:
-0.84%
H:
0.73%
C:
0.23%
treatment
disease
market
Global Cancer Immunotherapy Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published:
2022-04-06
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-7.68%
|
O:
0.23%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-12.71%
|
O:
4.21%
H:
0.0%
C:
-0.61%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-1.68%
|
O:
1.45%
H:
0.46%
C:
0.19%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
5.15%
|
O:
1.98%
H:
0.0%
C:
-1.11%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
2.68%
|
O:
0.39%
H:
0.53%
C:
0.44%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-19.26%
|
O:
1.15%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-11.99%
|
O:
1.01%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
145.48%
|
O:
-0.27%
H:
2.95%
C:
1.12%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-35.94%
|
O:
0.05%
H:
2.52%
C:
2.49%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-13.52%
|
O:
1.74%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
-1.17%
|
O:
0.35%
H:
2.64%
C:
2.45%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
6.8%
|
O:
-0.29%
H:
1.42%
C:
0.98%
immunotherapy
cancer
market
Dragonfly Therapeutics Announces Achievement of Phase 1 Clinical Development Milestone for IL-12 Investigational Immunotherapy Program with Bristol Myers Squibb
Published:
2022-03-01
(Crawled : 19:00)
- biospace.com/
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-29.72%
|
O:
-0.8%
H:
1.31%
C:
0.75%
il-12
program
therapeutics
immunotherapy
one
phase 1
therapy
phase 2
milestone
Artificial Intelligence Being Used to Accurately Predict Synergistic Cancer Drug Combinations
Published:
2021-12-10
(Crawled : 19:00)
- prnewswire.com
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
Email alert
Add to watchlist
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
Email alert
Add to watchlist
MRK
|
$125.23
-0.11%
0.0%
6M
|
Health Technology
|
Email alert
Add to watchlist
artificial intelligence
drug
cancer drug
cancer
Global Lymphoma Treatment Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published:
2021-12-01
(Crawled : 19:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
18.86%
|
O:
0.15%
H:
0.0%
C:
0.0%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
15.5%
|
O:
-1.01%
H:
0.65%
C:
0.21%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-8.42%
|
O:
-0.26%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
200.81%
|
O:
-1.21%
H:
0.0%
C:
0.0%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-10.48%
|
O:
2.17%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-14.84%
|
O:
-0.36%
H:
2.82%
C:
1.65%
treatment
growth
North America Cell Therapy Markets, 2021-2027 - Growing Collaborative Efforts to Promote Cell Therapy & Developments in Cell Therapy Against COVID-19
Published:
2021-06-24
(Crawled : 19:00)
- prnewswire.com
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-26.71%
|
O:
0.12%
H:
1.76%
C:
1.23%
VCEL
|
$43.86
-5.19%
-5.47%
430K
|
Health Technology
|
-29.65%
|
O:
0.61%
H:
4.2%
C:
1.87%
MESO
|
$5.14
2.6%
2.53%
270K
|
Health Technology
|
-40.71%
|
O:
0.12%
H:
0.0%
C:
-3.31%
covid
therapy
growing
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma....
Published:
2021-04-16
(Crawled : 19:00)
- biospace.com/
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-25.11%
|
O:
0.76%
H:
1.09%
C:
0.82%
food
therapy
cancer
drug
nivolumab
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.